Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEPOSITION-2: Timing of IV Tranexamic Acid in Cardiac Surgery
NCT06622564Phase 3Not yet recruiting
- Sponsor
- Hamilton Health Sciences
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid (2 arms), sponsored by Hamilton Health Sciences. Primary endpoint: Plasma Tranexamic Acid Concentration. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT06622564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06622564.